PMC:7105881 / 57924-58171
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1735 | 178-183 | Species | denotes | human | Tax:9606 |
| 1736 | 184-197 | Species | denotes | coronaviruses | Tax:11118 |
| 1737 | 225-233 | Species | denotes | SARS-CoV | Tax:694009 |
| 1738 | 238-246 | Species | denotes | MERS-CoV | Tax:1335626 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T277 | 225-233 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T669 | 178-183 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T309 | 0-247 | Sentence | denotes | It is prospected that more structure-guided novel strategies will be developed to improve the overall immunogenicity and efficacy of subunit vaccines against emerging pathogenic human coronaviruses, including those targeting SARS-CoV and MERS-CoV. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T962 | 102-116 | BV_15 | denotes | immunogenicity |
| T963 | 178-183 | SP_6;NCBITaxon:9606 | denotes | human |
| T964 | 184-197 | NCBITaxon:11118 | denotes | coronaviruses |
| T965 | 225-233 | SP_10 | denotes | SARS-CoV |
| T966 | 238-246 | SP_9 | denotes | MERS-CoV |
| T95833 | 102-116 | BV_15 | denotes | immunogenicity |
| T22346 | 178-183 | SP_6;NCBITaxon:9606 | denotes | human |
| T65614 | 184-197 | NCBITaxon:11118 | denotes | coronaviruses |
| T79036 | 225-233 | SP_10 | denotes | SARS-CoV |
| T84510 | 238-246 | SP_9 | denotes | MERS-CoV |